Geode Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.4M | Buy |
|
|||||
|
2025
Q1 | $15.9M | Buy |
|
|||||
|
2024
Q4 | $13.1M | Buy |
|
|||||
|
2024
Q3 | $17.9M | Buy |
|
|||||
|
2024
Q2 | $10.2M | Buy |
|
|||||
|
2024
Q1 | $8.96M | Buy |
|
|||||
|
2023
Q4 | $4.74M | Buy |
|
|||||
|
2023
Q3 | $3.04M | Buy |
|
|||||
|
2023
Q2 | $4.38M | Buy |
|
|||||
|
2023
Q1 | $2.63M | Buy |
|
|||||
|
2022
Q4 | $2.83M | Buy |
|
|||||
|
2022
Q3 | $1.18M | Buy |
|
|||||
|
2022
Q2 | $948K | Sell |
|
|||||
|
2022
Q1 | $1.27M | Sell |
|
|||||
|
2021
Q4 | $2.61M | Buy |
|
|||||
|
2021
Q3 | $1.85M | Sell |
|
|||||
|
2021
Q2 | $6.82M | Buy |
|
|||||
|
2021
Q1 | $9.54M | Buy |
|
|||||
|
2020
Q4 | $891K | Buy |
|